Thailand

7 Vaccines Approved for Use in Thailand

• Serum Institute of India
  COVOVAX (Novavax formulation)

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 6 countries

  7 trials in 3 countries

  Approval Source: seekingalpha.com

  Protein Subunit

• Moderna
  Spikevax

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 88 countries

  70 trials in 24 countries

  Approval Source: reuters.com

  RNA

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  100 trials in 31 countries

  Approval Source: reuters.com

  RNA

• Janssen (Johnson & Johnson)
  Jcovden

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 113 countries

  26 trials in 25 countries

  Approval Source: reuters.com

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Approval Source: bnnbloomberg.ca

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 93 countries

  39 trials in 18 countries

  Approval Source: reuters.com

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  42 trials in 10 countries

  Approval Source: reuters.com

  Inactivated

12 Vaccines in Clinical Trials in Thailand

• Medigen
  MVC-COV1901

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 4 countries

  15 trials in 4 countries

  Protein Subunit

• SK Bioscience Co Ltd
  SKYCovione

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 1 country

  7 trials in 6 countries

  Protein Subunit

• Pfizer/BioNTech
  Comirnaty

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  100 trials in 31 countries

  RNA

• Janssen (Johnson & Johnson)
  Jcovden

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 113 countries

  26 trials in 25 countries

  Non Replicating Viral Vector

• Mahidol University; Butantan Institute; Mount Sinai
  NDV-HXP-S

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 3 trials.

  7 trials in 3 countries

  Non Replicating Viral Vector

• Oxford/AstraZeneca
  Vaxzevria

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 149 countries

  73 trials in 34 countries

  Non Replicating Viral Vector

• Sinopharm (Beijing)
  Covilo

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 93 countries

  39 trials in 18 countries

  Inactivated

• Sinovac
  CoronaVac

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine is approved.

  Approved in 56 countries

  42 trials in 10 countries

  Inactivated

• Chulalongkorn University
  ChulaCov19

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  5 trials in 2 countries

  RNA

• Chulalongkorn University
  ChulaCov19-BNA159 mRNA Vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 2 trials.

  2 trials in 1 country

  RNA

• Baiya Phytopharm Co Ltd
  Baiya SARS-CoV-2 Vax 1 Vaccine

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Protein Subunit

• Baiya Phytopharm Co Ltd
  Baiya SARS-CoV-2 Vax 2

  • Phase 1
  • Phase 2
  • Phase 3
  • Approved

  This vaccine has reached Phase 1 trials.

  1 trial in 1 country

  Protein Subunit